Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II study of BN-Brachyury in chordoma shows signs of clinical activity

Dec. 21, 2020

Interim analysis update on remestemcel-L study in COVID-19 ARDS

Dec. 21, 2020

Metacrine reports phase I data on FXR agonist MET-642

Dec. 21, 2020

FDA clears IND for AlloVir's ALVR-106 to treat severe respiratory viral infections

Dec. 18, 2020

Shionogi initiates phase I/II study in Japan with COVID-19 vaccine candidate

Dec. 18, 2020

Albireo starts phase III trial of odevixibat in Alagille syndrome

Dec. 18, 2020

First-in-human data presented for AB-928 with or without IPI-549 in patients with cancer

Dec. 18, 2020

EDP-1503 plus pembrolizumab safe and well-tolerated in TNBC patients

Dec. 18, 2020

Phase II trials of ALX-629 begin in COVID-19, atopic asthma and psoriasis

Dec. 18, 2020

New hMPV-derived vaccines presented by Valneva

Dec. 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...